These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4161198)

  • 41. [The use of immunofluorescence in identification and isolation of pathogenic Escherichia coli].
    Zacchi T; Rottini GD
    Riv Ist Sieroter Ital; 1968; 43(3):122-43. PubMed ID: 4883544
    [No Abstract]   [Full Text] [Related]  

  • 42. Bactericidal effect of the air-fluidized bed.
    Sharbaugh RJ; Hargest TS
    Am Surg; 1971 Sep; 37(9):583-6. PubMed ID: 4942219
    [No Abstract]   [Full Text] [Related]  

  • 43. [Sensitivity and applicability of immunofluorescent methods in the diagnosis of infections due to enteropathogenic strains of E. coli].
    Manikowska E; Bilińska M
    Pediatr Pol; 1974 Jan; 49(1):45-8. PubMed ID: 4590598
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions.
    Aoki S; Merkel M; Aoki M; McCabe WR
    J Lab Clin Med; 1967 Aug; 70(2):204-12. PubMed ID: 5339482
    [No Abstract]   [Full Text] [Related]  

  • 45. Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infections.
    Helfand MS; Bonomo RA
    Clin Infect Dis; 2006 Dec; 43(11):1415-6. PubMed ID: 17083013
    [No Abstract]   [Full Text] [Related]  

  • 46. A foodborne outbreak of Vero cytotoxin-producing Escherichia coli O157:H-phage type 8 in hospital.
    O'Brien SJ; Murdoch PS; Riley AH; King I; Barr M; Murdoch S; Greig A; Main R; Reilly WJ; Thomson-Carter FM
    J Hosp Infect; 2001 Nov; 49(3):167-72. PubMed ID: 11716633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on bacterial contamination within a surgical clinic].
    Chiari HH; Neuhold R
    Bruns Beitr Klin Chir (1971); 1965 Nov; 211(3):375-85. PubMed ID: 5328304
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the rapid diagnosis of pathogenic colibacillus by means of fluorescent antibodies].
    KOEDITZ H; WEINERT A
    Kinderarztl Prax; 1960 Nov; 28():513-20. PubMed ID: 13757426
    [No Abstract]   [Full Text] [Related]  

  • 49. [Multiple infections with dyspepsia coli, their statistical, bacteriological and clinical evaluation].
    LINDE K; KOEDITZ H; FUNK G
    Z Hyg Infektionskr; 1960; 147():94-108. PubMed ID: 13762281
    [No Abstract]   [Full Text] [Related]  

  • 50. Updating advances in cytogenetics.
    Miller OJ
    Birth Defects Orig Artic Ser; 1974; 10(8):1-5. PubMed ID: 4142399
    [No Abstract]   [Full Text] [Related]  

  • 51. [Highly active fluorescent antibodies with differently colored fluorescence to 14 serotypes of Escherichia coli].
    Tikhomirova VG; Riabtseva VA; Gusarova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):108-11. PubMed ID: 4590979
    [No Abstract]   [Full Text] [Related]  

  • 52. The unitized patient isolator: a microbiological demonstration of its reliability.
    Shadomy S
    Mil Med; 1966 Jun; 131(6):539-47. PubMed ID: 4956703
    [No Abstract]   [Full Text] [Related]  

  • 53. [Culture media problems in the diagnosis of dyspepsia coli].
    RUSCHMANN E
    Z Hyg Infektionskr; 1958; 144(4):307-15. PubMed ID: 13558301
    [No Abstract]   [Full Text] [Related]  

  • 54. Serologic relations that may lead to erroneous diagnoses of Escherichia coli infections by means of fluorescent antibody technics.
    DAVIS BR; EWING WH
    Tech Bull Regist Med Technol; 1963 Jan; 33():6-10. PubMed ID: 14025451
    [No Abstract]   [Full Text] [Related]  

  • 55. [On staining of paraagglutinating strains of Escherichia coli with fluorescent sera of different specificity].
    MIKHAILOV IF; LAVRENT'EV NI
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Aug; 32():74-8. PubMed ID: 14473692
    [No Abstract]   [Full Text] [Related]  

  • 56. Scottish Antibody Production Unit (SAPU).
    Munro AC; Wallace J
    Health Bull (Edinb); 1978 May; 36(3):131-3. PubMed ID: 659103
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fluorescence serological demonstration of coli dyspepsia in routine operation. Problems of economy and technique].
    Gebert P
    Z Arztl Fortbild (Jena); 1965 Feb; 59(3):146-51. PubMed ID: 4161198
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experiences in the demonstration of dyspepsia coli bacteria by means of fluorescent antiserums].
    Bösenberg H
    Arch Hyg Bakteriol; 1968 Dec; 152(5):453-6. PubMed ID: 4907117
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the diagnosis of dyspepsia coli bacteria by the indirect fluorescent antibody technique (sandwich method)].
    Heinrich S; Burckhardt F
    Zentralbl Bakteriol Orig; 1971; 216(2):193-8. PubMed ID: 4928075
    [No Abstract]   [Full Text] [Related]  

  • 60. [On demonstration of E. coli O 91 in dyspepsia].
    Ruckdeschel G; Linzenmeier G
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):276-7. PubMed ID: 4869924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.